Q4 2025 · 13F-HR
Alphabet Inc. (GOOG, GOOGL)holdings as filed
Filed 2026-02-13 · accession 0001652044-26-000023
$2.58B
Reported value
29
Positions
2025-12-31
Period end
The Brief · Alphabet Inc. (GOOG, GOOGL) · Q4 2025
AI · grounded in 13F
Alphabet Inc. (GOOG, GOOGL) closed its position in METSERA INC, reducing its holdings by $197.9M. The fund also exited positions in DNTH for $8.2M and FHTX for $2.4M. Additionally, it trimmed shares of MAZE by 42.4% and GLUE by 49.1%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00217D100 | ASTS | AST SPACEMOBILE INC | $649.6M | 25.2% | 8,943,486 | Common | SHARED |
| 72703X106 | PL | PLANET LABS PBC | $629.9M | 24.4% | 31,942,641 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $266.4M | 10.3% | 3,345,102 | Common | SHARED |
| 042068205 | ARM | ARM HOLDINGS PLC | $214.3M | 8.31% | 1,960,784 | Common | SHARED |
| 358054104 | FRSH | FRESHWORKS INC | $198.5M | 7.70% | 16,206,643 | Common | SHARED |
| 90364P105 | PATH | UIPATH INC | $115.3M | 4.47% | 7,034,337 | Common | SHARED |
| 37637K108 | GTLB | GITLAB INC | $102.3M | 3.96% | 2,724,712 | Common | SHARED |
| 88023B103 | TEM | TEMPUS AI INC | $91.6M | 3.55% | 1,551,102 | Common | SHARED |
| 252131107 | DXCM | DEXCOM INC | $68.8M | 2.67% | 1,036,937 | Common | SHARED |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $57.5M | 2.23% | 1,388,583 | Common | SHARED |
| 74168J101 | PRME | PRIME MEDICINE INC | $57.5M | 2.23% | 16,562,498 | Common | SHARED |
| 107924102 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $35.3M | 1.37% | 2,823,126 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $13.3M | 0.51% | 1,568,753 | Common | SHARED |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $12.2M | 0.47% | 241,264 | Common | SHARED |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $11.7M | 0.45% | 744,948 | Common | SHARED |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $11.4M | 0.44% | 2,812,500 | Common | SHARED |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $9.0M | 0.35% | 293,256 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $8.9M | 0.35% | 321,604 | Common | SHARED |
| 316841105 | FIG | FIGMA INC | $8.1M | 0.31% | 215,582 | Common | SHARED |
| 687793109 | OSCR | OSCAR HEALTH INC | $6.9M | 0.27% | 481,988 | Common | SHARED |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $3.0M | 0.11% | 22,711 | Common | SHARED |
| 30063P105 | EXK | EXACT SCIENCES CORP | $2.4M | 0.09% | 23,205 | Common | SHARED |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $2.1M | 0.08% | 889,979 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.4M | 0.05% | 698,262 | Common | SHARED |
| 44916K106 | HYPR | HYPERFINE INC | $880,746 | 0.03% | 898,720 | Common | SHARED |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $650,151 | 0.03% | 915,705 | Common | SHARED |
| 22053A107 | QNCX | QUINCE THERAPEUTICS INC | $633,559 | 0.02% | 189,122 | Common | SHARED |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $161,303 | 0.01% | 14,262 | Common | SHARED |
| 759916109 | RGEN | REPLIGEN CORP | $62,758 | 0.00% | 383 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.